Compare
Fractyl Health, Inc. vs Baxter International Inc vs 3M Co vs Teleflex Inc
| Latest fiscal year | Fractyl Health, Inc. GUTS | Baxter International Inc BAX | 3M Co MMM | Teleflex Inc TFX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $0 | $11.24B | $24.95B | $1.99B |
| Revenue growth (YoY) | -100.0% | +5.7% | +1.5% | +17.2% |
| Gross margin | n/a | 30.1% | 39.9% (computed) | 56.2% |
| Operating margin | n/a | -2.7% | 18.6% | 5.9% |
| Net margin | n/a | -8.5% | 13.0% | -45.4% |
| Net income | -$140.95M | -$957.00M | $3.25B | -$905.64M |
| EPS (Diluted) | -$1.86 | -$1.87 | $6.00 | -$20.25 |
| Operating cash flow | -$90.33M | $845.00M | $2.31B | $96.68M |
| Free cash flow | -$90.89M | $332.00M | $1.40B | $1.45M |
| Cash & equivalents | $81.54M | $1.97B | n/a | $378.56M |
| Total assets | $121.40M | $20.05B | $37.73B | $6.95B |
| Total liabilities | $111.94M | $13.95B | $32.99B | $3.82B |
| Shareholders' equity | $9.46M | $6.10B | $4.75B | $3.12B |
| Return on year-end equity | n/m | -15.7% | 68.5% | -29.0% |
| Shares outstanding | 153.37M | n/a | 530.28M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Fractyl Health, Inc. | Baxter International Inc | 3M Co | Teleflex Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2025-12-31 | $11.24B Ended 2025-12-31 | $24.95B Ended 2025-12-31 | $1.99B Ended 2025-12-31 |
| 1 year earlier | $93.0K Ended 2024-12-31 | $10.64B Ended 2024-12-31 | $24.57B Ended 2024-12-31 | $1.70B Ended 2024-12-31 |
| 2 years earlier | $120.0K Ended 2023-12-31 | $10.36B Ended 2023-12-31 | $24.61B Ended 2023-12-31 | $1.71B Ended 2023-12-31 |
| 3 years earlier | n/a | $10.06B Ended 2022-12-31 | $26.16B Ended 2022-12-31 | $2.79B Ended 2022-12-31 |
| 4 years earlier | n/a | $12.15B Ended 2021-12-31 | $35.35B Ended 2021-12-31 | $2.81B Ended 2021-12-31 |